An update on bone imaging and markers in chronic kidney disease
Explore this paper's citation graph
Summary
This review aims to summarize the risk factors for, and spectrum of bone disease in CKD, as well as appraise the clinical utility of dual energy X-ray densitometry, peripheral quantitative computed tomography, high-resolution peripheral quantitative computation, and bone turnover markers.
- Type
- article
- Published
- 2016-09-28
- Cited by
- 0
- References
- 172
- OpenAlex
- https://openalex.org/W2523987884
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:51864522
Keywords
Medicine, Kidney disease, Gold standard (test), Quantitative computed tomography, Radiology
References
- Severely reduced production of klotho in human chronic renal failure kidney.
- Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.
- Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
- Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover
- Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.
- Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis.
- Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.
- Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry.
- Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
- Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
- Bone fragility and imaging techniques.
- Official positions of the International Society for Clinical Densitometry.
- A Randomized, Double‐Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
- The importance of klotho in phosphate metabolism and kidney disease
- Biochemical markers of bone turnover: part I: biochemistry and variability.
- Sclerostin and DKK1: new players in renal bone and vascular disease.
- Rapid cortical bone loss in patients with chronic kidney disease
- Trabecular Bone Score: A Noninvasive Analytical Method Based Upon the DXA Image
- Mortality and complications after hip fracture among elderly patients undergoing hemodialysis
- Bone density measurements in pediatric patients with renal osteodystrophy
Cited by
No citing papers recorded for this paper.
Related papers
- [Bone densitometry--the gold standard for diagnosis of osteoporosis].
- Региональные аспекты трёхмерной остеоденситометрии у женщин
- Metabolic bone disease in adolescents: recognition, evaluation, treatment, and prevention.
- BONE DISEASE IN RENAL TRANSPLANT PATIENTS, STUDY OF CLINICAL FACTORS, INFLUENCE AND CORRELATION WITH BONE LOSS MEASURED BY BONE DENSITOMETRY.: 2228
- [Biochemical markers of bone metabolism: clinical value in general practice].
- Clinical use of markers of bone turnover in metastatic bone disease
- Bone metabolism in rheumatoid arthritis
- Clinical utility of biochemical markers of bone metabolism for improving the management of patients with advanced multiple myeloma.